Literature DB >> 22356496

Polypharmacy--we make it worse! A cross-sectional study from an acute admissions unit.

T M Betteridge1, C M Frampton, D L Jardine.   

Abstract

Although polypharmacy is a major problem in the elderly, very few data have been published from Australasia. We retrospectively audited 68% of elderly patients admitted acutely to our medical unit (n= 424, mean age 80.3 ± 8 years) during a 30-day period (September, 2008). We found that long-term medications increased during hospital stay from 6.6 ± 4 to 7.7 ± 4 (P < 0.001). Adverse drug reactions were responsible for 24 admissions (5.7%). Polypharmacy is made worse by acute admission to hospital.
© 2012 The Authors. Internal Medicine Journal © 2012 Royal Australasian College of Physicians.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22356496     DOI: 10.1111/j.1445-5994.2011.02690.x

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  9 in total

1.  The epidemiology of polypharmacy.

Authors:  Rupert A Payne
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

2.  Medication regimen complexity and prevalence of potentially inappropriate medicines in older patients after hospitalisation.

Authors:  Wei Terk Chang; Stefan R Kowalski; Wassana Sorich; Christopher P Alderman
Journal:  Int J Clin Pharm       Date:  2017-05-26

3.  Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study.

Authors:  Barbara Caecilia Wimmer; Elsa Dent; Renuka Visvanathan; Michael David Wiese; Kristina Johnell; Ian Chapman; J Simon Bell
Journal:  Drugs Aging       Date:  2014-08       Impact factor: 3.923

4.  A pilot study of a Medication Rationalization (MERA) intervention.

Authors:  Rachel Whitty; Sandra Porter; Kiran Battu; Pranjal Bhatt; Ellen Koo; Csilla Kalocsai; Peter Wu; Kendra Delicaet; Isaac I Bogoch; Robert Wu; James Downar
Journal:  CMAJ Open       Date:  2018-02-16

Review 5.  Multi-Morbidity and Polypharmacy in Older People: Challenges and Opportunities for Clinical Practice.

Authors:  Pritti Aggarwal; Stephen J Woolford; Harnish P Patel
Journal:  Geriatrics (Basel)       Date:  2020-10-28

6.  Incidence of adverse drug events in patients hospitalized in the medical wards of a teaching referral hospital in Ethiopia: a prospective observational study.

Authors:  Teketel Alemu Ersulo; Mengist Awoke Yizengaw; Behailu Terefe Tesfaye
Journal:  BMC Pharmacol Toxicol       Date:  2022-05-17       Impact factor: 2.605

7.  Polypharmacy in the elderly from the clinical toxicologist perspective.

Authors:  H J Heppner; M Christ; M Gosch; W Mühlberg; P Bahrmann; T Bertsch; C Sieber; K Singler
Journal:  Z Gerontol Geriatr       Date:  2012-08       Impact factor: 1.281

Review 8.  Does Having a Usual Primary Care Provider Reduce Polypharmacy Behaviors of Patients With Chronic Disease? A Retrospective Study in Hubei Province, China.

Authors:  Jia Wang; Zhanchun Feng; Zhongxin Dong; Wanping Li; Chaoyi Chen; Zhichun Gu; Anhua Wei; Da Feng
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.810

9.  Challenges and Enablers of Deprescribing: A General Practitioner Perspective.

Authors:  Nagham J Ailabouni; Prasad S Nishtala; Dee Mangin; June M Tordoff
Journal:  PLoS One       Date:  2016-04-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.